Makes sense. Thanks for the reply and opinion. I always appreciate hints about what could happen from folks that for whatever reason may possess a little more insight.
I have to ask though, and don't feel like you have to answer even if you know, is the alternative route the Humanitarian Device Exemption Program for valve in valve procedures? Because there was a photo of a slide about that from the internal strategy meeting last October that Anteris posted to Twitter (the maximum number of devices that can be sold under the program each year is 8,000 so the projection is obviously that many at $30,000 each):
AVR Price at posting:
$20.57 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)